NovoCure Limited (NVCR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 11:22AM EDT. Market open.
| Previous close | 23.70 |
| Open | 23.49 |
| Bid | 22.60 x 200 |
| Ask | 22.76 x 200 |
| Day's range | 22.34 - 23.49 |
| 52-week range | 10.87 - 82.64 |
| Volume | |
| Avg. volume | 1,390,141 |
| Market cap | 2.441B |
| Beta (5Y monthly) | 0.49 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.81 |
| Earnings date | 02 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.92 |
Insider MonkeyNovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript
NovoCure Limited (NASDAQ:NVCR) Q1 2024 Earnings Call Transcript May 2, 2024 NovoCure Limited beats earnings expectations. Reported EPS is $-0.36134, expectations were $-0.43. NVCR isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for standing by. […]
GuruFocus.comNovoCure Ltd (NVCR) Q1 2024 Earnings: Revenue Surpasses Estimates, Narrower Net Loss Reported
Comprehensive Analysis of NovoCure's First Quarter Financial Performance
ZacksNovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
NovoCure (NVCR) delivered earnings and revenue surprises of 16.28% and 5.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.